InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-10.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Aggarwal Sumit, Chairman & CEO. Officer active across 1 company, notably Eloxx Pharmaceuticals, Inc.. Aggregated, 3 reports have been published. History available since 1 December 2021. The latest transaction was filed on 24 January 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Aggarwal Sumit
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
30,000 shares0Common StockSEC:0001104659-25-006784:0
165,000 shares0Common StockSEC:0001104659-24-109519:0
279,158 shares0Common StockSEC:0001415889-21-005693:0
3 of 3 declarations
About Aggarwal Sumit
Sumit Aggarwal is the President and CEO of Eloxx Pharmaceuticals, Inc. He leads the company by setting the strategic vision and overseeing daily operations. His leadership is essential for the development of innovative therapeutic solutions.
